{"title":"对“四氢吖啶衍生物的发现和优化,作为一类新的抗生素,通过靶向I型信号肽酶和破坏细菌膜来对抗多重耐药的革兰氏阳性病原体”的更正[欧洲]。医学化学。Issn 0223-5234, (283, 2025, 117101)","authors":"Xiaolin Lu , Jinhu Huang","doi":"10.1016/j.ejmech.2025.117916","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":314,"journal":{"name":"European Journal of Medicinal Chemistry","volume":"296 ","pages":"Article 117916"},"PeriodicalIF":5.9000,"publicationDate":"2025-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Corrigendum to: “Discovery and optimization of tetrahydroacridine derivatives as a novel class of antibiotics against multidrug-resistant gram-positive pathogens by targeting type I signal peptidase and disrupting bacterial membrane” [Eur. J. Med. Chem. ISSN 0223–5234, (283, 2025, 117101]\",\"authors\":\"Xiaolin Lu , Jinhu Huang\",\"doi\":\"10.1016/j.ejmech.2025.117916\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":314,\"journal\":{\"name\":\"European Journal of Medicinal Chemistry\",\"volume\":\"296 \",\"pages\":\"Article 117916\"},\"PeriodicalIF\":5.9000,\"publicationDate\":\"2025-06-30\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"European Journal of Medicinal Chemistry\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0223523425006816\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"CHEMISTRY, MEDICINAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Journal of Medicinal Chemistry","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0223523425006816","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CHEMISTRY, MEDICINAL","Score":null,"Total":0}
Corrigendum to: “Discovery and optimization of tetrahydroacridine derivatives as a novel class of antibiotics against multidrug-resistant gram-positive pathogens by targeting type I signal peptidase and disrupting bacterial membrane” [Eur. J. Med. Chem. ISSN 0223–5234, (283, 2025, 117101]
期刊介绍:
The European Journal of Medicinal Chemistry is a global journal that publishes studies on all aspects of medicinal chemistry. It provides a medium for publication of original papers and also welcomes critical review papers.
A typical paper would report on the organic synthesis, characterization and pharmacological evaluation of compounds. Other topics of interest are drug design, QSAR, molecular modeling, drug-receptor interactions, molecular aspects of drug metabolism, prodrug synthesis and drug targeting. The journal expects manuscripts to present the rational for a study, provide insight into the design of compounds or understanding of mechanism, or clarify the targets.